(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - hVIVO PLC on Wednesday said it signed a GBP5.2 million contract with a "global biotechnology company" headquartered in Asia Pacific in order to test their respiratory syncytial virus vaccine candidate. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - hVivo PLC is targeting a profit by 2020, it said on Thursday, with a strong pipeline of work opportunities lying ahead.hVivo, which provides clinical development services, Read More
(Alliance News) - Induction Healthcare Group PLC said Friday it has appointed Shelley Fraser as chief financial officer on an interim basis with immediate effect.She will be replacing Seb a Read More
(Alliance News) - Clinical development firm hVIVO PLC said on Tuesday that it has completed the respiratory syncytial virus human challenge study on 60-75 year-old adults for positive tests found Read More
(Alliance News) - Clinical development firm hVivo PLC on Wednesday said it is to start a new anti-mosquito trial, while its finance chief has also left.hVivo is to start a trial at the of a Read More
(Alliance News) - hVIVO PLC on Tuesday said Jupiter Asset Management Ltd now holds an 11% stake in the scientific research company.Prior to this transaction on Monday, Jupiter's if any, Read More
LONDON (Alliance News) - hVIVO PLC on Thursday described 2018 as a "transitional" year as it posted a widened annual loss on impairment charges.For 2018, the drug discovery posted Read More
